Clinical Trial Update: Albumin Infusion Targets on Mortality in Patients With Abdominal Sepsis

View source ↗

Summary

This completed clinical trial evaluated whether different albumin infusion targets affect 28-day mortality in patients with abdominal sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Albumin

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: 28-day Mortality | Status: COMPLETED